Therapeutic form of arsenic is a potential treatment for deadly type of brain cancer
Arsenic trioxide has been used to fend off a rare subtype of blood cancer known as acute promyelocytic leukemia. Now, in a study led by Northwestern University and TGen, this anti-cancer agent is being considered for use against GB. The study was published in Molecular Cancer Research. October 17, 2017